Washington Drug Letter
Sept. 19, 2011
| Vol.
43 No.
37
Stop Pay-for-Delay Deals, FTC Tells Super Committee
The FTC is asking a special congressional committee on the federal deficit to restrict reverse settlements, continuing its quest to stop such deals between brand and generic-drug companies.
This article is viewable by subscribers only. To view this article, please select an option below.
|